Proto Script Pharmaceutical (Proto Script Pharmaceutical) Tangible Book per Share : $-0.03 (As of Sep. 2017)

Proto Script Pharmaceutical Tangible Book per Share Chart

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Tangible Book per Share	Get a 7-Day Free Trial															-	-	-0.02	-0.02	-0.03

Competitive Comparison of Proto Script Pharmaceutical's Tangible Book per Share

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical's Price-to-Tangible-Book Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Price-to-Tangible-Book falls into.

Proto Script Pharmaceutical Tangible Book per Share Calculation

Proto Script Pharmaceutical's Tangible Book Value Per Share for the fiscal year that ended in May. 2016 is calculated as

Proto Script Pharmaceutical's Tangible Book Value Per Share for the quarter that ended in Sep. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.

Proto Script Pharmaceutical  (OTCPK:PSCR) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Proto Script Pharmaceutical Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description